Literature DB >> 21236324

Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa.

Bitten Plesner1, Peter Westh, Anders D Nielsen.   

Abstract

The effects of GlycoPEGylation on the structural, kinetic and thermal stability of recombinant human FVIIa were investigated using rFVIIa and linear 10 kDa and branched 40 kDa GlycoPEGylated(®) recombinant human FVIIa derivatives. The secondary and tertiary structure of rFVIIa measured by circular dichroism (CD) was maintained upon PEGylation. In contrast, the thermal and kinetic stability of rFVIIa was affected by GlycoPEGylation, as the apparent unfolding temperature T(m) measured by differential scanning calorimetry (DSC) and the temperature of aggregation, T(agg), measured by light scattering (LS) both increased with GlycoPEGylation. Both T(m) and T(agg) were independent of the molecular weight and the shape of the PEG chain. From the present biophysical characterisation it is concluded that after GlycoPEGylation, rFVIIa appears to be unaffected structurally (secondary and tertiary structure), slightly stabilised thermally (unfolding temperature) and stabilised kinetically (temperature of aggregation).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236324     DOI: 10.1016/j.ijpharm.2010.12.034

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  N-PEGylation of a reverse turn is stabilizing in multiple sequence contexts, unlike N-GlcNAcylation.

Authors:  Joshua L Price; Evan T Powers; Jeffery W Kelly
Journal:  ACS Chem Biol       Date:  2011-09-22       Impact factor: 5.100

Review 2.  How PEGylation influences protein conformational stability.

Authors:  Paul B Lawrence; Joshua L Price
Journal:  Curr Opin Chem Biol       Date:  2016-08-28       Impact factor: 8.822

3.  Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin.

Authors:  Xiao Liu; Kobenan G W Kouassi; Rita Vanbever; Mireille Dumoulin
Journal:  Protein Sci       Date:  2022-09       Impact factor: 6.993

Review 4.  Site-Specific PEGylation of Therapeutic Proteins.

Authors:  Jonathan K Dozier; Mark D Distefano
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.